Masterclasses from the Wards

Masterclasses in Dermatology

S. Elman

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

2024 Clinical Case Studies

A. Geisler

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Tisch Cancer Institute at Mount Sinai

M. Metzger

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Symptomatic Profiles of Patients With Polycythemia Vera: Implication…

Alexander Coltoff

SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning Fro…

5th SOHO Italy Annual Conference

H. Hamed

A Real-World Evaluation of the Association Between Elevated Blood Co…

Aaron Gerds

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…

Tisch Cancer Institute at Mount Sinai

D. Tremblay, J. Mascarenhas, R. Sheppard, A. Shih, I. Sarami

The Role of Genomic Analysis and Panel Mutation Screening in the Con…

Michael Deininger

Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…

Richard T. Silver

ASCO 2022 Updates in Lymphoma and CLL

Total Health

W. Hammond

SOHO 2021 Next Questions in ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

B. Shah

SOHO 2021 Next Questions in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. O'Brien